Muhammad Ikram, Md Llc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 101 Broad St, Ashland, PA 17921 Phone: 570-875-2000 |
Synergy Counseling Services, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 935 Centre St, Ashland, PA 17921 Phone: 570-875-2271 Fax: 570-875-2281 |
St Catherine Medical Center Hospital Units - Psychiatric Unit Medicare: Not Enrolled in Medicare Practice Location: 101 Broad St, Ashland, PA 17921 Phone: 570-875-5810 Fax: 570-875-6773 |
Ashland Behavioral Center Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 632 Centre St, Ashland, PA 17921 Phone: 570-875-6422 Fax: 570-875-6426 |
Visualize Change, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 913 Centre St, Ashland, PA 17921 Phone: 570-875-3333 Fax: 570-875-3433 |
News Archive
Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the J.P. Morgan Healthcare Conference being held January 11 through 14, 2010 at the Westin St. Francis Hotel in San Francisco.
The Board issued a Notice of Hearing on March 16, 2009, pertaining to allegations of Board Staff that Neulasta had been, and was being, sold by Amgen Canada Inc. at prices exceeding those indicated by the Board's Excessive Price Guidelines. On October 13, 2009, the Hearing Panel received a Joint Submission by Amgen and Board Staff along with a Voluntary Compliance Undertaking ("VCU") which proposed to resolve the issues raised in the Neulasta proceedings.
Aromatase inhibitors, when used for up to three years in combination with growth hormone, may effectively and safely help very short adolescent boys grow taller, new research suggests. The study results will be presented Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society in Boston.
Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.
According to British researchers breathing in heavy traffic fumes can trigger a heart attack. Heart attack risk is raised for about six hours post-exposure and goes down again after that, researchers found. They say in the British Medical Journal that pollution probably hastens rather than directly cause attacks. But repeated exposure is still bad for health, they say, substantially shortening life expectancy, and so the advice to people remains the same - avoid as far as is possible.
› Verified 7 days ago